Answers are grounded in this paper and cite their sources.
Among patients with invasive EOC, having a germline mutation in BRCA1 or BRCA2 was associated with improved 5-year overall survival. BRCA2 carriers had the best prognosis.
No takes yet. Share an insight, caveat, or question.
Kelly L. Bolton (2012) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: